Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Momenta Pharma 301 BINNEY STREET CAMBRIDGE MA 02142 USA

P: 617-491-9700 F: 617-621-0431

Description:

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and its manufacturing process. They are applying their innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

Key Statistics

Overview:

Market Capitalization, $K 1,358,208
Shares Outstanding, K 98,707
Annual Sales, $ 75,590 K
Annual Net Income, $ -176,060 K
Last Quarter Sales, $ 5,180 K
Last Quarter Net Income, $ -113,970 K
60-Month Beta 2.03
% of Insider Shareholders 3.40%
% of Institutional Shareholders 96.21%
Float, K 95,351
% Float 96.60%

Growth:

1-Year Return -49.50%
3-Year Return 17.51%
5-Year Return 19.44%
5-Year Revenue Growth 113.11%
5-Year Earnings Growth 4.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.16 on 08/02/19
Next Earnings Date 11/06/19
Earnings Per Share ttm -2.14
EPS Growth vs. Prev Qtr -152.17%
EPS Growth vs. Prev Year -27.47%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

MNTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -11.06
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -55.24
Return-on-Assets (Before Tax) -41.51
Profit Margin % -232.91
Net Margin % 68.72
Debt/Equity 0.00
Price/Sales 18.11
Price/Cash Flow N/A
Price/Book 4.37
Book Value/Share 3.17
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar